Imatinib Mesylate Therapy Induces Reduction in Neutrophil Gelatinase-Associated Lipocalin Serum Levels and Increase in Leptin Concentrations in Chronic Myeloid Leukemia Patients in Molecular Remission

Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene

(2010) C Nishioka et al.   LEUKEMIA

Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera

(2010) Alessandro Allegra et al.   LEUKEMIA & LYMPHOMA

Upregulation of Neutrophil Gelatinase-Associated Lipocalin by ErbB2 through Nuclear Factor- B Activation

(2009) S.-H. Li et al.   CANCER RESEARCH

Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration

(2009) Kerstin Lang et al.   Cell Communication and Signaling

Expression patterns of leptin receptor (OB-R) isoforms and direct in vitro effects of recombinant leptin on OB-R, leptin expression and cytokine secretion by human hematopoietic malignant cells

(2009) Athanasia Mouzaki et al.   CYTOKINE

Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors

(2009) Chun-Meng Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies

(2008) Itaru Matsumura et al.   CANCER SCIENCE

Lipocalin 2 is required for BCR-ABL-induced tumorigenesis

(2008) X Leng et al.   ONCOGENE

A role for leptin in sustaining lymphopoiesis and myelopoiesis

(2008) K. Claycombe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA